Literature DB >> 27507108

Role of phytochemicals in the inhibition of epithelial-mesenchymal transition in cancer metastasis.

Eun-Kyung Kim1, Eun-Ju Choi, Trishna Debnath.   

Abstract

Epithelial-mesenchymal transition (EMT) is the process by which epithelial cells become mesenchymal cells, gaining fibroblast-like properties and displaying reduced intercellular adhesion and increased motility. EMT plays an important role in cancer metastasis. Suppressing or reversing EMT is therefore an important way of controlling various cancers. Phytochemicals are important sources of anticancer lead molecules. Natural products have been shown to safely suppress or reverse EMT via the inhibition of associated signalling pathways in various cancer cells. In the present review, we discuss the relevant factors and the role of EMT in cancer metastasis. We then present examples of phytochemicals with a role in the inhibition and reversal of EMT in various cancers, focusing on reports from 2012 to 2016.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27507108     DOI: 10.1039/c6fo00901h

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  5 in total

Review 1.  Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway.

Authors:  Haneen Amawi; Charles R Ashby; Temesgen Samuel; Ramalingam Peraman; Amit K Tiwari
Journal:  Nutrients       Date:  2017-08-21       Impact factor: 5.717

2.  Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.

Authors:  Wei Chen; Yi Liu; Hongde Chen; Hao Ning; Kejia Ding
Journal:  Int J Oncol       Date:  2017-06-12       Impact factor: 5.650

3.  Matrine inhibits the invasive and migratory properties of human hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.

Authors:  Yuwen Wang; Shujun Zhang; Jia Liu; Biaobiao Fang; Jie Yao; Binglin Cheng
Journal:  Mol Med Rep       Date:  2018-05-16       Impact factor: 2.952

4.  Yeast-Derived Recombinant Avenanthramides Inhibit Proliferation, Migration and Epithelial Mesenchymal Transition of Colon Cancer Cells.

Authors:  Federica Finetti; Andrea Moglia; Irene Schiavo; Sandra Donnini; Giovanni Nicolao Berta; Federica Di Scipio; Andrea Perrelli; Claudia Fornelli; Lorenza Trabalzini; Saverio Francesco Retta
Journal:  Nutrients       Date:  2018-08-24       Impact factor: 5.717

Review 5.  The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges.

Authors:  Chin-Yap Loh; Jian Yi Chai; Ting Fang Tang; Won Fen Wong; Gautam Sethi; Muthu Kumaraswamy Shanmugam; Pei Pei Chong; Chung Yeng Looi
Journal:  Cells       Date:  2019-09-20       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.